Medicare Program; Emergency Medical Treatment and Labor Act (EMTALA) Technical Advisory Group (TAG) Meeting-October 26, 2005 Through October 28, 2005, 55903-55905 [05-18925]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices
determined that this notice will not
have a significant effect on a substantial
number of small entities or on the
operations of a substantial number of
small rural hospitals. Therefore, we are
not preparing analyses for either the
RFA or section 1102(b) of the Act.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule that may result in expenditure in
any 1 year by State, local, or tribal
governments, in the aggregate, or by the
private sector, of $110 million. This
notice has no consequential effect on
State, local, or tribal governments. We
believe the private sector costs of this
notice fall below this threshold as well.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it publishes a proposed
rule (and subsequent final rule) that
imposes substantial direct compliance
costs on State and local governments,
preempts State law, or otherwise has
Federalism implications. We have
determined that this notice does not
significantly affect the rights, roles, and
responsibilities of States.
This notice announces that the
monthly actuarial rates applicable for
2006 are $176.90 for enrollees age 65
and over and $203.70 for disabled
enrollees under age 65. It also
announces that the monthly Part B
premium rate for calendar year 2006 is
$88.50 and that the Part B deductible for
calendar year 2006 is $124.00. The Part
B premium rate of $88.50 is 13.2 percent
higher than the $78.20 premium rate for
2005. We estimate that this increase will
cost approximately 40 million Part B
enrollees about $4.9 billion for 2006. In
addition, we estimate that the increase
in the annual deductible will cost
approximately $0.4 billion in 2006.
Therefore, this notice is a major rule as
defined in Title 5, United States Code,
section 804(2) and is an economically
significant rule under Executive Order
12866.
In accordance with the provisions of
Executive Order 12866, this notice was
reviewed by the Office of Management
and Budget.
IV. Waiver of Proposed Notice
The Medicare statute requires the
publication of the monthly actuarial
rates and the Part B premium amounts
in September. We ordinarily use general
notices, rather than notice and comment
rulemaking procedures, to make such
announcements. In doing so, we note
that, under the Administrative
Procedure Act, interpretive rules,
general statements of policy, and rules
of agency organization, procedure, or
VerDate Aug<31>2005
15:21 Sep 22, 2005
Jkt 205001
practice are excepted from the
requirements of notice and comment
rulemaking.
We considered publishing a proposed
notice to provide a period for public
comment. However, we may waive that
procedure if we find, for good cause,
that prior notice and comment are
impracticable, unnecessary, or contrary
to the public interest. We find that the
procedure for notice and comment is
unnecessary because the formula used
to calculate the Part B premium is
statutorily directed, and we can exercise
no discretion in applying that formula.
Moreover, the statute establishes the
time period for which the premium
rates will apply, and delaying
publication of the Part B premium rate
such that it would not be published
before that time would be contrary to
the public interest. Therefore, we find
good cause to waive publication of a
proposed notice and solicitation of
public comments.
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: September 12, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
Approved: September 15, 2005.
Michael O. Leavitt,
Secretary.
[FR Doc. 05–18837 Filed 9–16–05; 4 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1269–N5]
Medicare Program; Emergency Medical
Treatment and Labor Act (EMTALA)
Technical Advisory Group (TAG)
Meeting—October 26, 2005 Through
October 28, 2005
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
SUMMARY: In accordance with section
10(a) of the Federal Advisory Committee
Act (FACA) (5 U.S.C. Appendix 2), this
notice announces the third meeting of
the Emergency Medical Treatment and
Labor Act (EMTALA) Technical
Advisory Group (TAG). The purpose of
the EMTALA TAG is to review
regulations affecting hospital and
physician responsibilities under
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
55903
EMTALA to individuals who come to a
hospital seeking examination or
treatment for medical conditions. The
primary purpose of the third meeting is
to enable the EMTALA TAG to hear
additional testimony and further
consider written responses from
medical societies and other
organizations on specific issues
considered by the TAG at previous
meetings. However, the public is
permitted to attend this meeting and, to
the extent that time permits and at the
discretion of the Chairperson, the
EMTALA TAG may hear comments
from the floor.
DATES: Meeting Date: The meetings of
the EMTALA TAG announced in this
notice are as follows: Wednesday,
October 26, 2005, 9 a.m. to 5 p.m. e.s.t.;
Thursday, October 27, 2005, 11 a.m. to
5 p.m. e.s.t.; Friday, October 28, 2005,
9 a.m. to 12 noon e.s.t.
Registration Deadline: All individuals
must register to attend this meeting.
Individuals who wish to attend the
meeting but do not wish to present
testimony must register by October 19,
2005. Individuals who wish both to
attend the meeting and to present their
testimony must register by October 5,
2005, and must submit copies of their
testimony in writing by October 12,
2005.
Comment Deadline: Written
comments/statements to be presented to
the EMTALA TAG must be received by
October 12, 2005.
Special Accommodations: Individuals
requiring sign-language interpretation or
other special accommodations should
send a request to these services to
Beverly J. Parker by 5 p.m., October 12,
2005 at address listed below.
ADDRESSES: Meeting Address: The
EMTALA TAG meeting will be held in
the Multipurpose Room at the CMS
Headquarters (Central Bldg), 7500
Security Boulevard, Baltimore, MD
21244–1850.
Mailing and E-mail Addresses for
Inquiries or Comments: Inquiries or
comments regarding this meeting may
be sent to—Beverly J. Parker, Division of
Acute Care, Centers for Medicare &
Medicaid Services, Mail Stop C4–08–06,
7500 Security Boulevard, Baltimore, MD
21244–1850. Inquiries or comments may
also be e-mailed to
Beverly.Parker@cms.hhs.gov or
EMTALATAG@cms.hhs.gov.
Web Site Address for Additional
Information: For additional information
on the EMTALA TAG meeting agenda
topics, updated activities, and to obtain
Charter copies, please search our
Internet Web site at: https://
E:\FR\FM\23SEN1.SGM
23SEN1
55904
Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices
www.cms.hhs.gov/faca/emtalatag/
emtalatagpage.asp.
FOR FURTHER INFORMATION CONTACT:
Beverly J. Parker, (410) 786–5320;
George Morey, (410) 786–4653.
Press inquiries are handled through
the CMS Press Office at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1866(a)(1)(I), 1866(a)(1)(N),
and 1867 of the Social Security Act (the
Act) impose specific obligations on
Medicare-participating hospitals that
offer emergency services. These
obligations concern individuals who
come to a hospital emergency
department and request or have a
request made on their behalf for
examination or treatment for a medical
condition. EMTALA applies to all these
individuals, regardless of whether or not
they are beneficiaries of any program
under the Act. Section 1867 of the Act
sets forth requirements for medical
screening examinations for emergency
medical conditions, as well as necessary
stabilizing treatment or appropriate
transfer.
Regulations implementing the
EMTALA legislation are set forth at 42
CFR 489.20(l), (m), (q) and (r)(1), (r)(2),
(r)(3), and 489.24. Section 945 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173), requires
that the Secretary establish a Technical
Advisory Group (TAG) for advice
concerning issues related to EMTALA
regulations and implementation.
Section 945 of the MMA specifies that
the EMTALA TAG—
• Shall review the EMTALA
regulations;
• May provide advice and
recommendations to the Secretary
concerning these regulations and their
application to hospitals and physicians;
• Shall solicit comments and
recommendations from hospitals,
physicians, and the public regarding
implementation of such regulations; and
• May disseminate information
concerning the application of these
regulations to hospitals, physicians, and
the public.
The EMTALA TAG, as chartered
under the legal authority of section 945
of the MMA, is also governed by the
provisions of the Federal Advisory
Committee Act (FACA) (5 U.S.C.
Appendix 2) for the selection of
members and the conduct of all
meetings.
In the May 28, 2004 Federal Register
(69 FR 30654), we specified the
statutory requirements regarding the
charter, general responsibilities, and
VerDate Aug<31>2005
15:21 Sep 22, 2005
Jkt 205001
structure of the EMTALA TAG. That
notice also solicited nominations for
members based on the statutory
requirements for the EMTALA TAG. In
the August 27, 2004 Federal Register
(69 FR 52699), we solicited nominations
again for members in two categories
(patient representatives and a State
survey agency representative) for which
no nominations were received in
response to the May 28, 2004 Federal
Register notice. In the March 15, 2005
Federal Register (70 FR 12691), we
announced the inaugural meeting of the
EMTALA TAG and the membership
selection. In the May 18, 2005 Federal
Register (70 FR 28541) we announced
the second meeting of the EMTALA
TAG with a purpose to hear public
testimony and consider written
responses from medical societies and
other organizations on specific issues
considered by the EMTALA TAG at its
inaugural meeting. The EMTALA TAG
has established the following three
subcommittees:
• On-Call Subcommittee
(Chairperson, John Kusske, M.D.)
charged to review the testimony
provided and other materials to identify
some specific issues relating to on-call
requirements.
• Action Subcommittee (Chairperson,
Julie Nelson, J.D.) charged to identify
issues other than on-call issues.
• Framework Subcommittee
(Chairperson, Charlotte Yeh, M.D.)
charged to clarify the historical context
and conceptual basis for the TAG’s
recommendations and develop a
document for review and approval by
the TAG.
II. Meeting Format, Agenda, and
Presentation Topics
A. Meeting Format
The initial portion of the meeting
(convening at 9 a.m. on October 26) will
involve opening remarks, followed by a
limited period of public testimony on
emergency medical services and
specialty hospital issues. Participants
wishing to present testimony on the
EMTALA impact of specialty hospitals
are requested to address their comments
to the following issues:
• Whether there should be a Federal
requirement for specialty hospitals to
maintain emergency departments and, if
so, whether this is best achieved by
amending EMTALA or through some
other means.
• Whether specialty hospitals,
irrespective of whether they have
emergency departments, are subject to
the EMTALA requirement under which
a Medicare participating hospitals with
specialized capabilities or facilities may
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
not refuse to accept an appropriate
transfer of an individual who requires
such specialized capabilities or facilities
if the hospital has the capacity to treat
the individual.
• Whether additional or different, oncall requirements should be established
for specialty hospitals (for example,
whether specialty hospitals should be
required to participate in community
protocols).
The public testimony will be followed
by discussion of emergency medical
services (EMS), specialty hospitals, and
other issues under consideration by the
On-Call, Action, and Framework
Subcommittees. TAG members will be
afforded the opportunity to ask
questions, prioritize the topics
presented, and to conduct other
necessary business. At the conclusion of
each day’s meeting, to the extent that
time is available and at the discretion of
the Chair, the public will be permitted
a reasonable time to comment on issues
being considered by the TAG.
B. Tentative Meeting Agenda
The tentative agenda for the EMTALA
TAG meetings is as follows:
Day 1
Convenes at 9 a.m.
• Welcome, Call to Order, and
Opening Remarks.
• Administrative and Housekeeping
Issues.
• Public Testimony on Emergency
Medical Services and Specialty Hospital
Issues.
• Report of On-Call Subcommittee.
• Discussion of On-Call Issues.
• Report of Action Subcommittee.
• Discussion of Action Subcommittee
Issues (for example, psychiatric
emergency medical conditions and
stabilizing treatment; hospitals with
specialized capabilities; follow-up on
other issues discussed at the last TAG
meeting).
• Public Comment.
Day 2
Convenes at 11 a.m.
• Report of Framework
Subcommittee.
• Discussion of Framework Issues.
• Discussion of Specialty Hospital
Issues.
• Continuation of discussion of OnCall issues.
• Continuation of discussion of
Action Subcommittee Issues.
• Discussion of Current Business.
• Public Comment.
E:\FR\FM\23SEN1.SGM
23SEN1
Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices
Day 3
Convening at 9 a.m.
• Discussion of Current Business
(continued).
C. Public Presentations
Only individuals who register and
submit written testimony as specified in
section IV. of this notice will be
considered registered presenters. The
time allotted for each presentation will
be approximately 5 minutes but will be
based on the number of registered
presenters. Presenters will speak in their
assigned order. If registered presenters
are not given an opportunity to speak
because of time restrictions, we will
accept and present their testimony to
the TAG members. Comments from
other participants (individuals who are
not registered presenters) may be heard
after the scheduled testimonies, if time
permits.
If there are individuals who cannot
attend the meeting but wish to submit
comments/statements regarding
emergency medical services or specialty
hospitals, we will accept and present
their written comments/statements at
the meeting if their comments/
statements are received via postal mail
or email at the address listed in the
ADDRESSES section of this notice by
October 12, 2005.
III. Registration Instructions
The Center for Medicare Management
is coordinating meeting registration.
While there is no registration fee, all
individuals must register to attend due
to limited seating. As specified in the
DATES section of this notice, individuals
who wish to attend the meeting but do
not plan to present testimony must
register by October 19, 2005. Individuals
who would like both to attend and to
present testimony on the topics of
emergency medical services or specialty
hospitals must register by October 5,
2005 and must state specifically in their
registration request that they wish to
present testimony for EMTALA TAG
consideration. A copy of the presenter’s
written testimony must be received by
CMS at the address specified in the
ADDRESSES section of this notice by
October 12, 2005.
You may register with Marianne
Myers at Marianne.Myers@cms.hhs.gov
or by, fax to the attention of Marianne
Myers at (410) 786–0681, or by
telephone at (410) 786–5962. All
registration requests must include your
name, name of the organization (if
applicable), address, telephone and fax
numbers, e-mail address (if available).
You will receive a registration
confirmation with instructions for your
VerDate Aug<31>2005
15:21 Sep 22, 2005
Jkt 205001
arrival at the CMS Headquarters. If
seating has been reached, you will be
notified that the meeting has reached
capacity. All registrants are asked to
arrive at the CMS (Central Building) no
later than 20 minutes before the
scheduled starting time of each meeting
session they wish to attend.
IV. Security Information
Since this meeting will be held in a
Federal government building, Federal
security measures are applicable. As
noted above, in planning your arrival
time, we recommend allowing
additional time to clear security. All
vehicles will be inspected inside and
out at the entrance to the grounds. In
order to gain access to the building,
participants must bring a governmentissued photo identification (driver’s
license, passport, etc.) and a copy of
your registration information for the
meeting. Access may be denied to
persons without proper identification.
All persons entering the building
must pass through a metal detector. In
addition, all items brought to CMS,
whether personal or for the purpose of
demonstration or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
demonstration or to support a
presentation.
Authority: Section 945 of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA).
(Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: September 13, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 05–18925 Filed 9–22–05; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3159–N]
Medicare Program; Meeting of the
Medicare Coverage Advisory
Committee—November 29, 2005
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
55905
SUMMARY: This notice announces a
public meeting of the Medicare
Coverage Advisory Committee (MCAC).
The Committee provides advice and
recommendations about whether
scientific evidence is adequate to
determine whether certain medical
items and services are reasonable and
necessary under the Medicare statute.
This meeting concerns the treatments
for age-related macular degeneration.
Notice of this meeting is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)).
DATES: The public meeting will be held
on Tuesday, November 29, 2005 from
7:30 a.m. until 4:30 p.m. e.s.t.
Deadlines: Deadline for Presentations
and Comments: Written comments and
presentations must be received by
October 31, 2005, 5 p.m., e.s.t.
Deadline for Registration to Attend
Meeting: For security reasons,
individuals wishing to attend this
meeting must register by close of
business on November 22, 2005.
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to notify the Executive Secretary
by November 22, 2005 (see FOR FURTHER
INFORMATION CONTACT).
ADDRESSES: The meeting will be held in
the main auditorium of the Centers for
Medicare & Medicaid Services, 7500
Security Blvd., Baltimore, MD 21244.
FOR FURTHER INFORMATION CONTACT:
Michelle Atkinson, Executive Secretary,
by telephone at 410–786–2881 or by
e-mail at
Michelle.Atkinson@cms.hhs.gov.
Web Site: You may access up-to-date
information on this meeting at https://
www.cms.hhs.gov/mcac/
default.asp#meetings.
Presentations And Comments:
Interested persons can present data,
information, or views orally or in
writing on issues pending before the
Committee. Please submit written
comments to Michelle Atkinson, by
e-mail at
Michelle.Atkinson@cms.hhs.gov, or by
mail to the Executive Secretary for
MCAC, Coverage and Analysis Group,
Office of Clinical Standards and
Quality, Centers for Medicare &
Medicaid Services, 7500 Security
Boulevard, Mail Stop C1–09–06,
Baltimore, MD 21244.
SUPPLEMENTARY INFORMATION:
I. Background
On December 14, 1998, we published
a notice in the Federal Register (63 FR
68780) to describe the Medicare
E:\FR\FM\23SEN1.SGM
23SEN1
]]>Agencies
[Federal Register Volume 70, Number 184 (Friday, September 23, 2005)]
[Notices]
[Pages 55903-55905]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18925]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-1269-N5]
Medicare Program; Emergency Medical Treatment and Labor Act
(EMTALA) Technical Advisory Group (TAG) Meeting--October 26, 2005
Through October 28, 2005
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a) of the Federal Advisory
Committee Act (FACA) (5 U.S.C. Appendix 2), this notice announces the
third meeting of the Emergency Medical Treatment and Labor Act (EMTALA)
Technical Advisory Group (TAG). The purpose of the EMTALA TAG is to
review regulations affecting hospital and physician responsibilities
under EMTALA to individuals who come to a hospital seeking examination
or treatment for medical conditions. The primary purpose of the third
meeting is to enable the EMTALA TAG to hear additional testimony and
further consider written responses from medical societies and other
organizations on specific issues considered by the TAG at previous
meetings. However, the public is permitted to attend this meeting and,
to the extent that time permits and at the discretion of the
Chairperson, the EMTALA TAG may hear comments from the floor.
DATES: Meeting Date: The meetings of the EMTALA TAG announced in this
notice are as follows: Wednesday, October 26, 2005, 9 a.m. to 5 p.m.
e.s.t.; Thursday, October 27, 2005, 11 a.m. to 5 p.m. e.s.t.; Friday,
October 28, 2005, 9 a.m. to 12 noon e.s.t.
Registration Deadline: All individuals must register to attend this
meeting. Individuals who wish to attend the meeting but do not wish to
present testimony must register by October 19, 2005. Individuals who
wish both to attend the meeting and to present their testimony must
register by October 5, 2005, and must submit copies of their testimony
in writing by October 12, 2005.
Comment Deadline: Written comments/statements to be presented to
the EMTALA TAG must be received by October 12, 2005.
Special Accommodations: Individuals requiring sign-language
interpretation or other special accommodations should send a request to
these services to Beverly J. Parker by 5 p.m., October 12, 2005 at
address listed below.
ADDRESSES: Meeting Address: The EMTALA TAG meeting will be held in the
Multipurpose Room at the CMS Headquarters (Central Bldg), 7500 Security
Boulevard, Baltimore, MD 21244-1850.
Mailing and E-mail Addresses for Inquiries or Comments: Inquiries
or comments regarding this meeting may be sent to--Beverly J. Parker,
Division of Acute Care, Centers for Medicare & Medicaid Services, Mail
Stop C4-08-06, 7500 Security Boulevard, Baltimore, MD 21244-1850.
Inquiries or comments may also be e-mailed to
Beverly.Parker@cms.hhs.gov or EMTALATAG@cms.hhs.gov.
Web Site Address for Additional Information: For additional
information on the EMTALA TAG meeting agenda topics, updated
activities, and to obtain Charter copies, please search our Internet
Web site at: https://
[[Page 55904]]
www.cms.hhs.gov/faca/emtalatag/emtalatagpage.asp.
FOR FURTHER INFORMATION CONTACT: Beverly J. Parker, (410) 786-5320;
George Morey, (410) 786-4653.
Press inquiries are handled through the CMS Press Office at (202)
690-6145.
SUPPLEMENTARY INFORMATION:
I. Background
Sections 1866(a)(1)(I), 1866(a)(1)(N), and 1867 of the Social
Security Act (the Act) impose specific obligations on Medicare-
participating hospitals that offer emergency services. These
obligations concern individuals who come to a hospital emergency
department and request or have a request made on their behalf for
examination or treatment for a medical condition. EMTALA applies to all
these individuals, regardless of whether or not they are beneficiaries
of any program under the Act. Section 1867 of the Act sets forth
requirements for medical screening examinations for emergency medical
conditions, as well as necessary stabilizing treatment or appropriate
transfer.
Regulations implementing the EMTALA legislation are set forth at 42
CFR 489.20(l), (m), (q) and (r)(1), (r)(2), (r)(3), and 489.24. Section
945 of the Medicare Prescription Drug, Improvement, and Modernization
Act of 2003 (MMA) (Pub. L. 108-173), requires that the Secretary
establish a Technical Advisory Group (TAG) for advice concerning issues
related to EMTALA regulations and implementation.
Section 945 of the MMA specifies that the EMTALA TAG--
Shall review the EMTALA regulations;
May provide advice and recommendations to the Secretary
concerning these regulations and their application to hospitals and
physicians;
Shall solicit comments and recommendations from hospitals,
physicians, and the public regarding implementation of such
regulations; and
May disseminate information concerning the application of
these regulations to hospitals, physicians, and the public.
The EMTALA TAG, as chartered under the legal authority of section
945 of the MMA, is also governed by the provisions of the Federal
Advisory Committee Act (FACA) (5 U.S.C. Appendix 2) for the selection
of members and the conduct of all meetings.
In the May 28, 2004 Federal Register (69 FR 30654), we specified
the statutory requirements regarding the charter, general
responsibilities, and structure of the EMTALA TAG. That notice also
solicited nominations for members based on the statutory requirements
for the EMTALA TAG. In the August 27, 2004 Federal Register (69 FR
52699), we solicited nominations again for members in two categories
(patient representatives and a State survey agency representative) for
which no nominations were received in response to the May 28, 2004
Federal Register notice. In the March 15, 2005 Federal Register (70 FR
12691), we announced the inaugural meeting of the EMTALA TAG and the
membership selection. In the May 18, 2005 Federal Register (70 FR
28541) we announced the second meeting of the EMTALA TAG with a purpose
to hear public testimony and consider written responses from medical
societies and other organizations on specific issues considered by the
EMTALA TAG at its inaugural meeting. The EMTALA TAG has established the
following three subcommittees:
On-Call Subcommittee (Chairperson, John Kusske, M.D.)
charged to review the testimony provided and other materials to
identify some specific issues relating to on-call requirements.
Action Subcommittee (Chairperson, Julie Nelson, J.D.)
charged to identify issues other than on-call issues.
Framework Subcommittee (Chairperson, Charlotte Yeh, M.D.)
charged to clarify the historical context and conceptual basis for the
TAG's recommendations and develop a document for review and approval by
the TAG.
II. Meeting Format, Agenda, and Presentation Topics
A. Meeting Format
The initial portion of the meeting (convening at 9 a.m. on October
26) will involve opening remarks, followed by a limited period of
public testimony on emergency medical services and specialty hospital
issues. Participants wishing to present testimony on the EMTALA impact
of specialty hospitals are requested to address their comments to the
following issues:
Whether there should be a Federal requirement for
specialty hospitals to maintain emergency departments and, if so,
whether this is best achieved by amending EMTALA or through some other
means.
Whether specialty hospitals, irrespective of whether they
have emergency departments, are subject to the EMTALA requirement under
which a Medicare participating hospitals with specialized capabilities
or facilities may not refuse to accept an appropriate transfer of an
individual who requires such specialized capabilities or facilities if
the hospital has the capacity to treat the individual.
Whether additional or different, on-call requirements
should be established for specialty hospitals (for example, whether
specialty hospitals should be required to participate in community
protocols).
The public testimony will be followed by discussion of emergency
medical services (EMS), specialty hospitals, and other issues under
consideration by the On-Call, Action, and Framework Subcommittees. TAG
members will be afforded the opportunity to ask questions, prioritize
the topics presented, and to conduct other necessary business. At the
conclusion of each day's meeting, to the extent that time is available
and at the discretion of the Chair, the public will be permitted a
reasonable time to comment on issues being considered by the TAG.
B. Tentative Meeting Agenda
The tentative agenda for the EMTALA TAG meetings is as follows:
Day 1
Convenes at 9 a.m.
Welcome, Call to Order, and Opening Remarks.
Administrative and Housekeeping Issues.
Public Testimony on Emergency Medical Services and
Specialty Hospital Issues.
Report of On-Call Subcommittee.
Discussion of On-Call Issues.
Report of Action Subcommittee.
Discussion of Action Subcommittee Issues (for example,
psychiatric emergency medical conditions and stabilizing treatment;
hospitals with specialized capabilities; follow-up on other issues
discussed at the last TAG meeting).
Public Comment.
Day 2
Convenes at 11 a.m.
Report of Framework Subcommittee.
Discussion of Framework Issues.
Discussion of Specialty Hospital Issues.
Continuation of discussion of On-Call issues.
Continuation of discussion of Action Subcommittee Issues.
Discussion of Current Business.
Public Comment.
[[Page 55905]]
Day 3
Convening at 9 a.m.
Discussion of Current Business (continued).
C. Public Presentations
Only individuals who register and submit written testimony as
specified in section IV. of this notice will be considered registered
presenters. The time allotted for each presentation will be
approximately 5 minutes but will be based on the number of registered
presenters. Presenters will speak in their assigned order. If
registered presenters are not given an opportunity to speak because of
time restrictions, we will accept and present their testimony to the
TAG members. Comments from other participants (individuals who are not
registered presenters) may be heard after the scheduled testimonies, if
time permits.
If there are individuals who cannot attend the meeting but wish to
submit comments/statements regarding emergency medical services or
specialty hospitals, we will accept and present their written comments/
statements at the meeting if their comments/statements are received via
postal mail or email at the address listed in the ADDRESSES section of
this notice by October 12, 2005.
III. Registration Instructions
The Center for Medicare Management is coordinating meeting
registration. While there is no registration fee, all individuals must
register to attend due to limited seating. As specified in the DATES
section of this notice, individuals who wish to attend the meeting but
do not plan to present testimony must register by October 19, 2005.
Individuals who would like both to attend and to present testimony on
the topics of emergency medical services or specialty hospitals must
register by October 5, 2005 and must state specifically in their
registration request that they wish to present testimony for EMTALA TAG
consideration. A copy of the presenter's written testimony must be
received by CMS at the address specified in the ADDRESSES section of
this notice by October 12, 2005.
You may register with Marianne Myers at Marianne.Myers@cms.hhs.gov
or by, fax to the attention of Marianne Myers at (410) 786-0681, or by
telephone at (410) 786-5962. All registration requests must include
your name, name of the organization (if applicable), address, telephone
and fax numbers, e-mail address (if available). You will receive a
registration confirmation with instructions for your arrival at the CMS
Headquarters. If seating has been reached, you will be notified that
the meeting has reached capacity. All registrants are asked to arrive
at the CMS (Central Building) no later than 20 minutes before the
scheduled starting time of each meeting session they wish to attend.
IV. Security Information
Since this meeting will be held in a Federal government building,
Federal security measures are applicable. As noted above, in planning
your arrival time, we recommend allowing additional time to clear
security. All vehicles will be inspected inside and out at the entrance
to the grounds. In order to gain access to the building, participants
must bring a government-issued photo identification (driver's license,
passport, etc.) and a copy of your registration information for the
meeting. Access may be denied to persons without proper identification.
All persons entering the building must pass through a metal
detector. In addition, all items brought to CMS, whether personal or
for the purpose of demonstration or to support a presentation, are
subject to inspection. We cannot assume responsibility for coordinating
the receipt, transfer, transport, storage, set-up, safety, or timely
arrival of any personal belongings or items used for demonstration or
to support a presentation.
Authority: Section 945 of the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (MMA).
(Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program)
Dated: September 13, 2005.
Mark B. McClellan,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 05-18925 Filed 9-22-05; 8:45 am]
BILLING CODE 4120-01-P
